2024-09-03 - Analysis Report
##  ISRG Stock Analysis

**Company Overview:** Intuitive Surgical, Inc. (ISRG) is a leading medical device company that develops, manufactures, and markets robotic surgical systems. 

**1. Performance vs. S&P 500:**
- **Cumulative Return:** ISRG has returned 159.33% compared to the S&P 500's 89.66%, resulting in a **difference of 69.67%**.
- **Relative Divergence:** This difference puts ISRG at 98.59% of the maximum historical difference, indicating that it has outperformed the S&P 500 significantly.

**2. Recent Price Movement:**
- **Closing Price:** 492.63
- **5-Day Moving Average:** 484.71
- **20-Day Moving Average:** 474.02
- **60-Day Moving Average:** 449.66
- **Analysis:**  ISRG's price has been trending upwards in the short term, as evidenced by the price being above all three moving averages.

**3. Technical Indicators:**
- **RSI:** 75.94, indicating the stock is in overbought territory.
- **PPO:** -0.01, suggesting potential for a short-term price correction.
- **Delta_Previous_Relative_Divergence:** -1.41, indicating a short-term downward trend.
- **Expected Return:** 1.0%, suggesting potential for modest growth over the next five years.

**4. Recent Earnings & Outlook:**
- **Recent Earnings:**  
    - **Date:** 2024-07-19
    - **EPS:** 1.48 (Analysts' Estimate: 1.45)
    - **Revenue:** 2.01 B$ (Analysts' Estimate: 1.98 B$)
- **Analysis:**  ISRG surpassed analysts' earnings and revenue estimates for the most recent quarter, demonstrating continued strong performance.

**5. Overall Analysis:**
ISRG is a high-performing company with a strong track record of outperforming the broader market. While the current high RSI value suggests potential for a short-term correction, the company's recent earnings beat and consistent growth outlook suggest long-term potential. However, investors should consider the short-term price trend and overbought condition before making investment decisions. 

**6. Additional Considerations:**
- **Market conditions:** The broader market environment could significantly impact ISRG's performance. 
- **Competition:** ISRG faces competition from other medical device companies.
- **Regulatory approvals:**  The company relies heavily on regulatory approvals for its products.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Consult with a financial professional before making any investment decisions. 
